B-cell responses to ITP treatments.
Etienne Crickx1, Matthieu Mahévas1
1Centre national de référence des cytopénies auto-immunes de l'adulte, Hôpital Henri Mondor, Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy for immUne disordErs, Assistance Publique Hôpitaux de Paris (AP-HP), Université Paris Est Créteil, Créteil, France.
British Journal of Haematology
|December 29, 2023
Summary
Regulatory B cell deficiency is implicated in immune thrombocytopenia. However, patient treatments significantly impact these cells, affecting research findings on immune thrombocytopenia.
Area of Science:
- Immunology
- Hematology
Background:
- Immune thrombocytopenia (ITP) is an autoimmune disorder.
- Regulatory B cells (Bregs) play a crucial role in immune homeostasis.
- A deficiency in Bregs has been proposed in ITP pathogenesis.
Purpose of the Study:
- To investigate the impact of systemic immunosuppression on peripheral blood regulatory B cells in patients with immune thrombocytopenia.
- To highlight the importance of treatment history in immunological analyses for ITP.
Main Methods:
- Analysis of peripheral blood samples from patients with immune thrombocytopenia.
- Assessment of regulatory B cell populations in relation to treatment status.
Main Results:
- Systemic immunosuppressive treatments were found to deplete peripheral blood regulatory B cells in ITP patients.
- Treatment history is a critical confounding factor for immunological studies in ITP.
Conclusions:
- The observed Bregs deficiency in ITP may be influenced by ongoing treatments.
- Future immunological studies in ITP must account for patient treatment regimens to ensure accurate interpretation of results.
More Related Videos
Related Concept Videos
01:24B Cell Activation and Differentiation
1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
140
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
140
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
01:40Cell-mediated Immune Responses
68.3K
Overview
68.3K
01:36Humoral Immune Responses
72.7K
Overview
72.7K